Hengsong Cao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University

发表论文 9 篇 · 总被引 190 次 · h-index 7

代表论文

• Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma (2023 · Journal for ImmunoTherapy of Cancer · 被引 59)
• Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy (2022 · Journal for ImmunoTherapy of Cancer · 被引 37)
• GJB2 Promotes HCC Progression by Activating Glycolysis Through Cytoplasmic Translocation and Generating a Suppressive Tumor Microenvironment Based on Single Cell RNA Sequencing (2024 · Advanced Science · 被引 24)
• GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway (2023 · Journal for ImmunoTherapy of Cancer · 被引 22)
• New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma (2024 · Chinese Journal of Cancer Research · 被引 15)
• RAC1high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis (2024 · Cancer Letters · 被引 13)